These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19432907)

  • 1. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.
    Kaspar RW; Allen HD; Montanaro F
    J Am Acad Nurse Pract; 2009 May; 21(5):241-9. PubMed ID: 19432907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystrophin-Deficient Cardiomyopathy.
    Kamdar F; Garry DJ
    J Am Coll Cardiol; 2016 May; 67(21):2533-46. PubMed ID: 27230049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
    Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
    Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac assessment in duchenne and becker muscular dystrophies.
    Romfh A; McNally EM
    Curr Heart Fail Rep; 2010 Dec; 7(4):212-8. PubMed ID: 20857240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
    Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers.
    Schade van Westrum S; Dekker L; de Haan R; Endert E; Ginjaar I; de Visser M; van der Kooi A
    BMC Neurol; 2013 Jul; 13():88. PubMed ID: 23870371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological management of dilated cardiomyopathy in Duchenne muscular dystrophy: A systematic review.
    Haddad CN; Ali S; Stephanou D; Assakura MS; Sahagian L; Trogkanis E
    Hellenic J Cardiol; 2023; 74():58-64. PubMed ID: 37406964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy.
    Kaspar RW; Allen HD; Ray WC; Alvarez CE; Kissel JT; Pestronk A; Weiss RB; Flanigan KM; Mendell JR; Montanaro F
    Circ Cardiovasc Genet; 2009 Dec; 2(6):544-51. PubMed ID: 20031633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
    Bourke JP
    Dev Med Child Neurol; 2006 Mar; 48(3):164. PubMed ID: 16483389
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel dystrophin deletion mutation in a becker muscular dystrophy patient with early-onset dilated cardiomyopathy.
    Guo X; Dai Y; Cui L; Fang Q
    Can J Cardiol; 2014 Aug; 30(8):956.e1-3. PubMed ID: 24996370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to american academy of pediatrics recommendations for cardiac care among female carriers of duchenne and becker muscular dystrophy.
    Bobo JK; Kenneson A; Kolor K; Brown MA
    Pediatrics; 2009 Mar; 123(3):e471-5. PubMed ID: 19254982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving therapeutic strategies for dystrophinopathies: potential for conflict between cardiac and skeletal needs.
    Colan SD
    Circulation; 2005 Nov; 112(18):2756-8. PubMed ID: 16267247
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel Rod Domain Duplication in Dystrophin Resulting in X-Linked Dilated Cardiomyopathy.
    Chamberlain RC; Smith EC; Campbell MJ
    Pediatr Neurol; 2015 Nov; 53(5):439-41. PubMed ID: 26294044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duchenne Muscular Dystrophy: the Heart of the Matter.
    Shih JA; Folch A; Wong BL
    Curr Heart Fail Rep; 2020 Jun; 17(3):57-66. PubMed ID: 32270339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilated cardiomyopathy and the dystrophin gene: an illustrated review.
    Oldfors A; Eriksson BO; Kyllerman M; Martinsson T; Wahlström J
    Br Heart J; 1994 Oct; 72(4):344-8. PubMed ID: 7833192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Ventricular Tonic Contraction as a Novel Biomarker of Cardiomyopathy in Duchenne Muscular Dystrophy.
    Su JA; Ramos-Platt L; Menteer J
    Pediatr Cardiol; 2016 Apr; 37(4):678-85. PubMed ID: 26714815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27.
    Tsuda T; Fitzgerald K; Scavena M; Gidding S; Cox MO; Marks H; Flanigan KM; Moore SA
    J Hum Genet; 2015 Mar; 60(3):151-5. PubMed ID: 25537791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics.
    Fayssoil A; Nardi O; Orlikowski D; Annane D
    Heart Fail Rev; 2010 Jan; 15(1):103-7. PubMed ID: 19943106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Involvement Classification and Therapeutic Management in Patients with Duchenne Muscular Dystrophy.
    Fayssoil A; Abasse S; Silverston K
    J Neuromuscul Dis; 2017; 4(1):17-23. PubMed ID: 28269790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
    English KM; Gibbs JL
    Dev Med Child Neurol; 2006 Mar; 48(3):231-5. PubMed ID: 16483403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.